CD8A and malaria: It is widely recognized that a successful pre-erythrocytic malaria vaccine must induce not only humoral immune responses but also CD8+ T-cell-mediated immune responses31–35 to inhibit the infection of the liver by sporozoites and to eliminate any resulting liver-stage parasites that develop in hepatocytes.